Susquehanna International Group, LLP Dia Medica Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$1.53 - $4.4 $15,606 - $44,880
10,200 New
10,200 $44,000
Q2 2022

Aug 15, 2022
BUY
$1.86 - $2.62 $23,250 - $32,750
12,500 Added 26.88%
59,000 $119,000
Q1 2022

May 16, 2022
BUY
$2.29 - $3.88 $77,173 - $130,756
33,700 Added 263.28%
46,500 $116,000
Q4 2021

Feb 14, 2022
BUY
$3.43 - $4.65 $43,904 - $59,520
12,800 New
12,800 $48,000

Others Institutions Holding DMAC

# of Institutions
36
Shares Held
3.87M
Call Options Held
1.3K
Put Options Held
1K
View Full List

About DiaMedica Therapeutics Inc.

DMAC Quotes by TradingView
  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $116M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email